Nonketotic Hyperglycinemia in Tunisia. Report upon a Series of 69 Patients

Abstract

Aim The aim of the study is to report on epidemiological, clinical, and biochemical characteristics of nonketotic hyperglycinemia (NKH) in Tunisia.

Methods Patients diagnosed with NKH in Laboratory of Biochemistry at Rabta hospital (Tunis, Tunisia) between 1999 and 2018 were included. Plasma and cerebrospinal fluid (CSF) free amino acids were assessed by ion exchange chromatography. Diagnosis was based on family history, patient's clinical presentation and course, and increased CSF to plasma glycine ratio.

Results During 20 years, 69 patients were diagnosed with NKH, with 25 patients originating from Kairouan region. Estimated incidences were 1:55,641 in Tunisia and 1:9,684 in Kairouan. Consanguinity was found for 73.9% of the patients and 42% of the families have history of infantile death due to a disease of similar clinical course than the propositus. Clinical symptoms initiated within the first week of life in 75% of the patients and within the first 3 months in 95.7% ones. The phenotype was severe in 76.8% of the patients. Main symptoms were hypotonia, feeding difficulties, coma, apnea, and seizures. Most patients died within few days to months following diagnosis. CSF to plasma glycine ratio was increased in all patients. CSF and plasma glycine levels were negatively correlated with age of disease onset and severity.

Conclusion NKH is quite frequent in Tunisia. Kairouan region has the highest NKH incidence rate, worldwide. However, due to lack of confirmatory enzymatic and genetic tests, NKH diagnosis was based on first-line biochemical tests. Characterization of causal mutations is needed for accurate diagnosis and prenatal diagnosis of this devastating life-threatening disease.

Keywords

cerebrospinal fluid - incidence - glycine - nonketotic hyperglycinemia

Patient Consent for Publication

Not required.

Ethics Approval

Local Ethic Committee at Rabta Hospital (ID, 19/HRT/15).

Authors' Contribution

M.F., H.S., and N.K. designed the study. F.N., S.H.T., A.J., and W.Z. performed biochemical analysis. F.N. and M.F. drafted the manuscript. A.B.C., S.B.M., M.C., F.A., K.B.H., H.M., H.S., N.M., A.G., K.M., I.T., M.C., and N.T. identified the cases presented, supplied the relevant clinical information, and reviewed the article for accuracy. All authors revised critically the manuscript for important intellectual content, approved the final version as submitted, and agree to be accountable for all aspects of the work.

Publikationsverlauf

Eingereicht: 18. Februar 2020

Angenommen: 09. April 2020

Artikel online veröffentlicht:
20. August 2020

• References

• 1 Hamosh Johnston MV. Nonketotic hyperglycinemia, In: Scriver CR, Beaudet AL, Sly WS, Valle D. , eds. The Metabolic and Molecular Bases of Inherited Disease, 11th ed. New York, NY: McGraw-Hill; 2001: 2065-2078
• 2 Rezvani Melvin JJ. Defects in metabolism of amino acids, In: Kliegman RM, Stanton BF, St GemeJ, Behrman RE. , eds. Nelson Textbook of Pediatrics. 19th ed.. Philadelphia, PA: Elsevier; 2011: 439-440
• 3 Van Hove JLK, Coughlin II C, Swanson M, Hennermann JB. Nonketotic hyperglycinemia. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A. , eds. Source Gene Reviews®. Seattle, WA: University of Washington, Seattle; 2002: 1993-2020
• 4 Coughlin II CR, Swanson MA, Kronquist K. , et al. The genetic basis of classic nonketotic hyperglycinemia due to mutations in GLDC and AMT. Genet Med 2017; 19 (01) 104-111
• 5 Khemir S, Tebib N, Nasrallah F. , et al. Phenylketonuria in Tunisian institutions for the mentally handicapped. Arch Dis Child 2009; 94 (08) 647-648
• 6 Hadj-Taieb S, Nasrallah F, Hammami MB. , et al. Aminoacidopathies and organic acidurias in Tunisia: a retrospective survey over 23 years. Tunis Med 2012; 90 (03) 258-261
• 7 Dinopoulos A, Matsubara Y, Kure S. Atypical variants of nonketotic hyperglycinemia. Mol Genet Metab 2005; 86 (1-2): 61-69
• 8 Hennermann JB, Berger JM, Grieben U, Scharer G, Van Hove JL. Prediction of long-term outcome in glycine encephalopathy: a clinical survey. J Inherit Metab Dis 2012; 35 (02) 253-261
• 9 Institut National de la Statistique. Available at: http://www.ins.tn/fr/statistiques . Accessed June 3, 2019
• 10 Veríssimo C, Garcia P, Simões M. , et al. Nonketotic hyperglycinemia: a cause of encephalopathy in children. J Child Neurol 2013; 28 (02) 251-254
• 11 von Wendt L, Hirvasniemi A, Similä S. Nonketotic hyperglycinemia. A genetic study of 13 Finnish families. Clin Genet 1979; 15 (05) 411-417
• 12 Applegarth DA, Toone JR, Lowry RB. Incidence of inborn errors of metabolism in British Columbia, 1969-1996. Pediatrics 2000; 105 (01) e10
• 13 Kure S, Rolland MO, Leisti J. , et al. Prenatal diagnosis of non-ketotic hyperglycinaemia: enzymatic diagnosis in 28 families and DNA diagnosis detecting prevalent Finnish and Israeli-Arab mutations. Prenat Diagn 1999; 19 (08) 717-720
• 14 Krawczak M, Barnes RH. How obedience of marriage rules may counteract genetic drift. J Community Genet 2010; 1 (01) 23-28
• 15 Santos S, da Silva Pequeno AA, Pessoa A. , et al. Increased prevalence of inherited neuromuscular disorders due to endogamy in Northeast Brazil: the need of community genetics services. J Community Genet 2014; 5 (03) 199-203
• 16 Swanson MA, Coughlin Jr CR, Scharer GH. , et al. Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemia. Ann Neurol 2015; 78 (04) 606-618